Standard Family Office’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,363
Closed -$191K 268
2022
Q3
$191K Hold
2,363
0.08% 40
2022
Q2
$212K Buy
+2,363
New +$239K 2.1% 12
2022
Q1
Sell
-1,993
Closed -$206K 171
2021
Q4
$206K Buy
1,993
+993
+99% +$115K 1.83% 13
2021
Q3
$125K Sell
1,000
-8,270
-89% -$1.07M 0.04% 15
2021
Q2
$1.15M Buy
9,270
+1,000
+12% +$126K 0.24% 36
2021
Q1
$977K Sell
8,270
-1,000
-11% -$117K 0.23% 30
2020
Q4
$1.09M Buy
+9,270
New +$1.02M 0.26% 27

Other funds holding MDT

Standard Family Office's MDT Position: Q4 2022 in Review

Standard Family Office sold out of Medtronic (MDT) in Q4 2022, closing a stake of 2,363 shares — an estimated $191K sold.

Standard Family Office first reported a position in MDT in Q4 2020 and held it in 7 quarters. The position peaked at $1.15M in Q2 2021. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Standard Family Office reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
  • Standard Family Office sold 2,363 Medtronic shares in Q4 2022, an estimated $191K.
  • Standard Family Office first reported a position in Medtronic in Q4 2020 and held it in 7 quarters.
  • Standard Family Office's Medtronic position peaked at $1.15M in Q2 2021.
  • 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.